Glycomic alterations are associated with multidrug resistance in human leukemia

International Journal of Biochemistry and Cell Biology

Volumn 44, Issue 8, 2012, Pages 1244-1253

  Zhang, Zhaohai ^a,b   Zhao, Yongfu ^a   Jiang, Lili ^a   Miao, Xiaoyan ^a   Zhou, Huimin ^a   Jia, Li ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Jinshan Hospital of Benxi   (China)

Author keywords

FITC lectin; Glycan; Glycomics; Human leukemia cell lines; Multidrug resistance

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; GLYCAN; GLYCOPEPTIDASE; LECTIN; PACLITAXEL; TUNICAMYCIN; VINCRISTINE;

ARTICLE; BIOSYNTHESIS; CELL STRAIN K 562; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG SENSITIVITY; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; GENE TARGETING; GLYCOBIOLOGY; GLYCOGENE; GLYCOSYLATION; HUMAN; HUMAN CELL; LECTIN BINDING; LEUKEMIA; MASS SPECTROMETRY; MULTIDRUG RESISTANCE; PHENOTYPE; PROTEIN GLYCOSYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL SURVIVAL; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOMICS; HUMANS; K562 CELLS; LECTINS; LEUKEMIA; N-ACETYLGLUCOSAMINYLTRANSFERASES; PACLITAXEL; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; POLYSACCHARIDES; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIALYLTRANSFERASES; TUNICAMYCIN; VINCRISTINE;

EID: 84861431411     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.04.026     Document Type: Article

References (41)

1. Bertozzi CR, Kiessling LL. Chemical glycobiology. Science 2001;291:2357-64. (Pubitemid 32231790)
2. Beretta GL, Benedetti V, Cossa G, Assaraf YG, Bram E, Gatti L, et al. Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin. Biochemical Pharmacology 2010;79:1108-17.
3. Bosch TM. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy. Methods in Molecular Biology 2008;448:63-76.
4. Breier A, Barancik M, Sulova Z, Uhrik B. P-glycoprotein simplications of metabolism of neoplastic cells and cancer therapy. Current Cancer Drug Targets 1995;5:457-68.
5. Brockhausen I. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Reports 2006;7:599-604. (Pubitemid 43827326)
6. Ciucanu I, Costello CE. Elimination of oxidative degradation during the per- O-methylation of carbohydrates. Journal of the American Chemical Society 2003;125:16213-9. (Pubitemid 38020645)
7. Costello CE, Contado-Miller JM, Cipollo JF. A glycomics platform for the analysis of permethylated oligosaccharide alditols. Journal of the American Society for Mass Spectrometry 2007;18:1799-812. (Pubitemid 47419346)
8. Dennis J, Waller C, Timpl R, Schirrmacher V. Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature 1982;300:274-6. (Pubitemid 13234738)
9. Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS. Beta1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987;236:582-5. (Pubitemid 17069927)
10. Didziapetris R, Japertas P, Avdeef A, Petrauskas A. Classification analysis of P-glycoprotein substrate specificity. Journal of Drug Targeting 2003;11: 391-406. (Pubitemid 38455825)
11. Dove A. The bittersweet promise of glycobiology. Nature Biotechnology 2001;19:913-7. (Pubitemid 32947569)
12. Dwek RA. Glycobiology: toward understanding the function of sugars. Chemical Reviews 1996;96:683-720. (Pubitemid 126649163)
13. Fiala R, Sulova Z, El-Saggan AH, Uhrik B, Liptaj T, Dovinova I, et al. P-glycoprotein-mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligo- and/or polysaccharide contents. Biochimica et Biophysica Acta 2003;1639:213-24. (Pubitemid 37424036)
14. Haltiwanger RS, Lowe JB. Role of glycosylation in development. Annual Review of Biochemistry 2004;73:491-537. (Pubitemid 39050378)
15. Inoue S, Salah-Eldin AE, Omoteyama K. Apoptosis and anticancer drug resistance. Human Cell 2001;14:211-21.
16. Jia L, Xu H, Zhao Y, Jiang L, Yu J, Zhang J. Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma. Cancer Investigation 2008;26:977-83.
17. Kim YS, Yoo HS, Ko JH. Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery. Protein and Peptide Letters 2009;16:499-507.
18. Kramer R, Weber TK, Arceci R, Ramchurren N, Kastrinakis WV, Steele GJ. Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype. British Journal of Cancer 1995;71:670-5.
19. Kudo T, Nakagawa H, Takahashi M, Hamaguchi J, Kamiyama N, Yokoo H, et al. N-glycan alternations are associated with drug resistance in human hepatocellular carcinoma. Molecular Cancer 2007;6:32-8.
20. Kvackajova-Kisucka J, Barancik M, Breier A. Drug transporters and their role in multidrug resistance of neoplastic cells. General Physiology and Biophysics 2001;20:215-37. (Pubitemid 33040351)
21. Lattová E, Tomanek B, Bartusik D, Perreault H. N-glycomic changes in human breast arcinoma MCF-7 and T-lymphoblastoid cells after treatment with herceptin and herceptin/Lipoplex. Journal of Proteome Research 2010;9:1533-40.
22. Li QQ, Wang WJ, Xu JD, Cao XX, Chen Q, Yang JM, et al. Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. Cancer Science 2007;98:1064-9. (Pubitemid 46865392)
23. Liu Z, Shen L, Xu L, Sun X, Zhou J, Wu S. Down-regulation of β-1, 3-N-acetylglucosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer. Molecular Medicine Report 2011;4:497-503.
24. Mantelli F, Schaffer L, Dana R, Head SR, Argueso P. Glycogene expression in conjunctiva of patients with dry eye: downregulation of notch signaling. Investigative Ophthalmology & Visual Science 2009;6:2666-72.
25. Mitra N, Sinha S, Ramya TN, Surolia A. N-linked oligosaccharides as outfitters for glycoprotein folding, form and function. Trends in Biochemical Sciences 2006;31:156-63. (Pubitemid 43357996)
26. Nakahara S, Miyoshi E, Noda K, Ihara S, Gu J, Honke K, et al. Involvement of oligosaccharide changes in α 5β 1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line. Molecular Cancer Therapeutics 2003;2:1207-14.
27. Nakayama J, Suzuki M, Suzuki M, Fukuda M. Expression profiling of glycosyltransferases and related enzymes using in situ hybridization. Methods in Enzymology 2006;416:120-9. (Pubitemid 44750107)
28. Naeem A, Saleemuddin M, Khan RH. Glycoprotein targeting and other applications of lectins in biotechnology. Current Protein and Peptide Science 2007;8: 261-71. (Pubitemid 46979728)
29. Pawagi AB, Wang J, Silverman M, Reithmeier RA, Deber CM. Transmembrane aromatic amino acid distribution in Pglycoprotein. A functional role in broad substrate specificity. Journal of Molecular Biology 1994;235:554-64.
30. Powell AK, Harvey DJ. Stabilization of sialic acids in N-linked oligosaccharides and gangliosides for analysis by positive ion matrix-assisted laser desorption/ionization mass spectrometry. Rapid Communications in Mass Spectrometry 1996;10:1027-32. (Pubitemid 26311551)
31. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science 2001;291:2370-6. (Pubitemid 32231792)
32. Solís D, Jiménez-Barbero J, Kaltner H, Romero A, Siebert HC, von der Lieth CW, et al. Towards defining the role of glycans as hardware in information storage and transfer: basic principles, experimental approaches and recent progress. Cells, Tissues, Organs 2001;168:5-23.
33. Sharom FJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 2008;9:105-27. (Pubitemid 351560534)
34. Schinkel AH, Kemp S, Dolle M, Rudenko G, Wagenaar E. N-Glycosylation and deletion mutants of the human MDR1 Pglycoprotein. Journal of Biological Chemistry 1993;268:7474-81. (Pubitemid 23105645)
35. Tang W, Chang SB, Hemler ME. Links between CD147 function glycosylation, and caveolin-1. Molecular Biology of the Cell 2004;15:4043-50. (Pubitemid 39122010)
36. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993;3:97-130. (Pubitemid 23132602)
37. Venable A, Mitalipova M, Lyons I, Jones K, Shin S, Pierce M, et al. Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces. BMC Development Biology 2005;21:5-15.
38. Viseux N, Costello CE, Domon B. Post-source decay mass spectrometry: optimized calibration procedure and structural characterization of permethylated oligosaccharides. Journal of Mass Spectrometry 1999;34:364-76. (Pubitemid 29182488)
39. Wang Y, Loo TW, Bartlett MC, Clarke DM. Modulating the folding of Pglycoprotein and cystic fibrosis transmembrane conductance regulator truncation mutants with pharmacological chaperones. Molecular Pharmacology 2007;71: 751-8. (Pubitemid 46294086)
40. Yang JM, Xu Z, Wu H, Zhu H, Wu X, Hait WN. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Molecular Cancer Research 2003;1:420-7. (Pubitemid 36459252)
41. Zaia J. Mass spectrometry of oligosaccharides. Mass Spectrometry Reviews 2004;23:161-227.